International Symposium
This two-day event will bring together leading international experts in the field of CRISPR technology and CRISPR applications in basic research in cancer and regenerative medicine. Attendees will have the opportunity to gain a deeper understanding of the potential and limitations of CRISPR as a research tool, both in precision genome engineering and in massively parallel, functional genomics applications and unbiased screens.
Confirmed Speakers
| Expanding the CRISPR screening toolbox with Cas12a, base editors, and more John Doench, Broad MIT |
| Better genome editing by listening to the cells Jacob Corn, ETH Zurich |
| Fine-tuning of transcription factor expression dosage uncovers non-linear effects in regulatory networks Tuuli Lappalainen, KTH and New York Genome Center |
| Uncovering key resistance mechanisms to cancer immunotherapy Yumeng Mao, Uppsala University |
| Harnessing the CRISPR toolbox to engineer biology Randall J. Platt, ETH Zurich |
| Target discovery – arrayed & pooled CRISPR screening to drive drug discovery Douglas Ross-Thriepland, AstraZeneca & CRUK Functional Genomics Centre |
| New frontiers in pooled CRISPR screens Neville Sanjana, New York Genome Center |
| CRISPR discovery platforms for human T cell therapies Eric Shifrut, Tel Aviv University |